- Home
- OLP vs SVRA Comparison
OLP vs SVRA Comparison
Compare OLP & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLP
- SVRA
- Stock Information
- Founded
- OLP 1982
- SVRA 2007
- Country
- OLP United States
- SVRA United States
- Employees
- OLP N/A
- SVRA N/A
- Industry
- OLP Real Estate Investment Trusts
- SVRA Biotechnology: Pharmaceutical Preparations
- Sector
- OLP Real Estate
- SVRA Health Care
- Exchange
- OLP Nasdaq
- SVRA Nasdaq
- Market Cap
- OLP 478.2M
- SVRA 527.2M
- IPO Year
- OLP N/A
- SVRA N/A
- Fundamental
- Price
- OLP $20.79
- SVRA $6.25
- Analyst Decision
- OLP
- SVRA Buy
- Analyst Count
- OLP 0
- SVRA 8
- Target Price
- OLP N/A
- SVRA $6.88
- AVG Volume (30 Days)
- OLP 125.6K
- SVRA 2.1M
- Earning Date
- OLP 11-06-2025
- SVRA 11-12-2025
- Dividend Yield
- OLP 8.64%
- SVRA N/A
- EPS Growth
- OLP N/A
- SVRA N/A
- EPS
- OLP 1.54
- SVRA N/A
- Revenue
- OLP $97,423,000.00
- SVRA N/A
- Revenue This Year
- OLP $8.44
- SVRA N/A
- Revenue Next Year
- OLP $3.05
- SVRA N/A
- P/E Ratio
- OLP $13.55
- SVRA N/A
- Revenue Growth
- OLP 9.29
- SVRA N/A
- 52 Week Low
- OLP $19.62
- SVRA $1.89
- 52 Week High
- OLP $30.46
- SVRA $6.37
- Technical
- Relative Strength Index (RSI)
- OLP 52.81
- SVRA 84.29
- Support Level
- OLP $20.02
- SVRA $5.09
- Resistance Level
- OLP $21.06
- SVRA $4.38
- Average True Range (ATR)
- OLP 0.42
- SVRA 0.35
- MACD
- OLP 0.10
- SVRA 0.15
- Stochastic Oscillator
- OLP 76.44
- SVRA 92.16
About OLP One Liberty Properties Inc.
One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.